Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
64.4M
-
Shares change
-
+13.4M
-
Total reported value, excl. options
-
$633M
-
Value change
-
+$133M
-
Number of buys
-
56
-
Number of sells
-
-27
-
Price
-
$9.84
Significant Holders of Edgewise Therapeutics, Inc. - Common Stock (EWTX) as of Q3 2022
97 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock as of Q3 2022.
Edgewise Therapeutics, Inc. - Common Stock (EWTX) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.4M shares
of 106M outstanding shares and own 60.83% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (14.6M shares), FMR LLC (7.98M shares), Novo Holdings A/S (6.07M shares), VIKING GLOBAL INVESTORS LP (4.41M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.93M shares), EcoR1 Capital, LLC (3.49M shares), Deep Track Capital, LP (3.37M shares), Cormorant Asset Management, LP (3.05M shares), CITADEL ADVISORS LLC (2.76M shares), and BlackRock Inc. (2.12M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.